FI950951A - Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi - Google Patents

Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi Download PDF

Info

Publication number
FI950951A
FI950951A FI950951A FI950951A FI950951A FI 950951 A FI950951 A FI 950951A FI 950951 A FI950951 A FI 950951A FI 950951 A FI950951 A FI 950951A FI 950951 A FI950951 A FI 950951A
Authority
FI
Finland
Prior art keywords
heart
treatment
blood flow
pharmaceutical agents
cardiac arrest
Prior art date
Application number
FI950951A
Other languages
English (en)
Swedish (sv)
Other versions
FI950951A0 (fi
Inventor
Elizabeth A Kitsis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI950951A0 publication Critical patent/FI950951A0/fi
Publication of FI950951A publication Critical patent/FI950951A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI950951A 1994-03-02 1995-03-01 Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi FI950951A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20484494A 1994-03-02 1994-03-02

Publications (2)

Publication Number Publication Date
FI950951A0 FI950951A0 (fi) 1995-03-01
FI950951A true FI950951A (fi) 1995-09-03

Family

ID=22759686

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950951A FI950951A (fi) 1994-03-02 1995-03-01 Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi

Country Status (11)

Country Link
EP (1) EP0679396A1 (fi)
JP (1) JPH07267859A (fi)
KR (1) KR950026521A (fi)
CN (1) CN1112919A (fi)
AU (1) AU1355095A (fi)
CA (1) CA2143544A1 (fi)
FI (1) FI950951A (fi)
HU (1) HUT71896A (fi)
IL (1) IL112747A0 (fi)
RU (1) RU95102777A (fi)
ZA (1) ZA951679B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6534651B2 (en) 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
ES2369522T3 (es) * 2005-12-21 2011-12-01 Pharming Intellectual Property B.V. Uso de un inhibidor c1 para la prevención de lesiones por isquemia-reperfusión.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3888574T2 (de) * 1987-04-24 1994-06-30 Abbott Lab Harnstoff-Derivate mit lipoxygenasehemmender Wirkung.
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
WO1991019497A1 (en) * 1990-06-12 1991-12-26 Smithkline Beecham Corporation Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
AU9137591A (en) * 1990-12-13 1992-07-08 Smithkline Beecham Corporation Novel csaids
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
FR2677477B1 (fr) * 1991-06-06 1993-08-20 Bellon Labor Sa Roger Nouveaux derives de l'oxazole leur preparation, leur utilisation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
CA2143544A1 (en) 1995-09-03
CN1112919A (zh) 1995-12-06
HU9500636D0 (en) 1995-04-28
JPH07267859A (ja) 1995-10-17
ZA951679B (en) 1996-09-02
HUT71896A (en) 1996-02-28
KR950026521A (ko) 1995-10-16
RU95102777A (ru) 1997-01-20
FI950951A0 (fi) 1995-03-01
EP0679396A1 (en) 1995-11-02
AU1355095A (en) 1995-09-07
IL112747A0 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
BR8703038A (pt) Estimulador cardiaco para deteccao e tratamento de taquiarritmias ventriculares do coracao de um paciente
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
FI952169A0 (fi) Stabiili valmiste veren koagulaatiohäiriöiden hoitamiseksi
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
FI962813A (fi) IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen
DE69924940D1 (de) Herzschrittmachersystem mit erweiterter Feststellung eines plötzlichen Herzrythmusabfalls und Behandlung mit einer darauf reagierende Herzreizung
KR960702315A (ko) 혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage)
NL187299B (nl) Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten.
FI950951A (fi) Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
FR2613617B1 (fr) Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine
FI952170A0 (fi) Koagulaatiota edistävää aktiivista ainetta sisältävä stabiili valmisteveren koagulaatiosairauksien hoitamiseksi
DE60007548D1 (de) Omega kettenmodifizierte hydroxyeicosatetraensäure derivate verwendbar in der behandlung der "trockenes auge" krankheit
IT1221010B (it) Impiego di chinoloni nel trattamento di malattie cardiache
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
IT1243734B (it) Composizione per uso terapeutico e/o cosmetico per il trattamento di disturbi circolatori e per trattamenti di medicina estetica
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
NO20001895D0 (no) Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer
IT8619086A0 (it) Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.